FRA Approves Al Nile Pharmaceuticals Disclosure Ahead of Capital Increase

The Egyptian Financial Regulatory Authority (FRA) has approved the disclosure report of Al Nile Pharmaceuticals and Chemical Industries regarding a capital increase. The decision paves the way for calling an extraordinary general assembly to consider the increase, which one report links to repaying loans.

AI-written summary of 2 sources; every verified point is backed by a verbatim quote. How Iyan works

• The Financial Regulatory Authority approved the disclosure report submitted by Al Nile Pharmaceuticals and Chemical Industries.

  «وافقت الهيئة العامة للرقابة المالية على اعتماد تقرير الإفصاح المقدم من شركة النيل للأدوية والصناعات الكيماوية»

  جريدة المال • جريدة البورصة
• The approval paves the way for calling an extraordinary general assembly to consider increasing the issued capital by 500 million pounds.

  «تمهيدًا لدعوة الجمعية العامة غير العادية للنظر في زيادة رأس المال المصدر من 500 مليون»

  جريدة المال
• The capital increase is linked to repaying loans, according to Al Borsa newspaper.

  «بشأن زيادة رأس المال، المرتبطة بسداد القروض.»

  جريدة البورصة

Iyan — See it for yourself. What changed in your world today, why it matters, and how we know.
How it works • Privacy • Terms